Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
The treatment of melanoma has been revolutionized by new therapies targeting MAPK signaling or the immune system. Unfortunately these therapies are hindered by either primary resistance or the development of acquired resistance. Resistance mechanisms involving somatic mutations in genes associated w...
Main Authors: | Stuart J Gallagher, Jessamy C Tiffen, Peter Hersey |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/7/4/0870 |
Similar Items
-
Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
by: Monika Krošel, et al.
Published: (2023-04-01) -
Image Scanning Microscopy to Investigate Polycomb Protein Colocalization onto Chromatin
by: Irene Nepita, et al.
Published: (2023-01-01) -
A Mathematical Model for the Treatment of Melanoma with the BRAF/MEK Inhibitor and Anti-PD-1
by: OPhir Nave, et al.
Published: (2022-12-01) -
Updates in Therapy for Advanced Melanoma
by: Bhavana P. Singh, et al.
Published: (2016-01-01) -
Polycomb Assemblies Multitask to Regulate Transcription
by: Miguel Vidal
Published: (2019-06-01)